Having trouble viewing this email? View in your browser.


06 February 2024

ECCMID 2024: Late-breaking abstracts submission is now open!

Late-breaking abstracts must pertain to new data that has not been published and was generated after the regular ECCMID 2024 abstracts submission.

For this year, we will exclusively consider abstracts in the following categories:

  • New drugs and vaccines
  • Clinical trials
  • New and emerging pathogens
  • Outbreaks and public health emergencies

Submission deadline is 14 February 2024, without possibility of extension.

Submit your late-breaking abstract here

You still have time to save on the ECCMID registration fee with Early Bird rates until 14 February 2024.


14 February 2024 | Deadline

ECCMID 2024 Early Bird Registration


14 February 2024 | Deadline

Group registration for Selective Pressure


14 February 2024 | Deadline

Late-breaking abstracts submission


29 Feb 2024 | Deadline

EUCIC Infection Prevention and Control Certificate

Deadline extended: Call for groups for ECCMID 2024 Selective Pressure

You still have time to form your groups of four persons to participate in Selective Pressure. All ECCMID 2024 attendees are welcome to join this session for an interactive educational and entertaining experience. The moderator of the session is Prof. Jesús Rodríguez-Baño.

Deadline for creating groups is 14 February 2024.

Register for this ESCMID online course
until 1 March

The focus of this course is helping professionals understand the basics and needs for AMS, as well as to develop and implement an AMS programme relevant to their setting

European Commission proposes measures to improve the availability of in vitro diagnostics

Following a statement of the BioMed Alliance about concerns regarding the availability of In Vitro Diagnostic Devices (IVDs) in Europe, the European Commission published a proposal to increase the time for companies to apply for the In Vitro Diagnostic Medical Devices Regulation (IVDR), under certain conditions. This is an important step towards ensuring patient care by improving the availability of these essential healthcare products.

2024 Call for ESCMID Guidelines projects

The ESCMID Guidelines Subcommittee invites ESCMID members and ESCMID Study Groups to submit proposals for clinical practice guidelines projects in the following topics:

  • Infection control and ICU standard procedures to reduce VAP
  • Diagnosis and treatment of endovascular graft infections
  • Diagnosis and treatment of Q fever

Deadline for project submission is 3 April 2024.

ECCMID 2024 Art Gallery: a big thank you to all contributors!

The full ECCMID 2024 Art Book is available now on the ECCMID website. We received an outstanding number of over 150 pieces of original art, which will be shared with the ECCMID community during the congress, both onsite and in the published online book.

Clinical relevance, mechanisms and evolution of polymyxin B heteroresistance carbapenem-resistant Klebsiella pneumoniae: a genomic, retrospective cohort study

The European Medicines Agency invites you to its annual edition of the EMA Veterinary Medicines Info Day to be held at the EMA on Thursday 14 March 2024 from 14:00 - 17:00 (CET) and Friday 15 March from 09:00 - 12:30 (CET)

ESCMID Executive Office
Aeschenvorstadt 55
4051 Basel

Phone +41 61 508 0150


The ESCMID Newsletter is issued on behalf of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) by the ESCMID Executive Office. It contains announcements of ESCMID-related matters and other information of interest to professionals in the infection field.

Tip: To ensure that you receive the ESCMID newsletter in your inbox, add newsletter@escmid.org to your email program's address book.

You have received this email as a contact of ESCMID or one of its affiliated societies. You can unsubscribe or change your newsletter subscriptions here.

. .